Earl A. Humphreys, M.D. v. Drug Enforcement Administration

105 F.3d 112, 1996 U.S. App. LEXIS 42576, 1996 WL 762112
Court of Appeals for the Third Circuit·Decided December 9, 1996·No. 96-3099·Published·Cited by 33 cases

Opinion

OPINION OF THE COURT

MICHEL, Circuit Judge.

The Drug Enforcement Administration (“DEA”) has moved this court pursuant to Third Circuit Appellate Rule 27.4 to vacate *113 our previously released decision and opinion resolving this appeal, Humphreys v. Drug Enforcement Administration, 96 F.3d 658 (3d Cir.1996), and to dismiss the appeal as moot. In that decision, we vacated the Deputy Administrator’s order entered pursuant to 21 U.S.C. § 824(a)(4) (1994) revoking Earl A. Humphreys’ Certificate of Registration to prescribe controlled substances. After the opinion was filed, but before the mandate issued, Dr. Humphreys died. The DEA argues Dr. Humphreys’ death moots the appeal, strips this court of jurisdiction, and requires that we vacate our decision and withdraw the opinion. Because we plainly had jurisdiction over the appeal at the time our opinion was filed, our decision whether to vacate is discretionary. For the prudential reasons set forth below, we deny the DEA’s motion to vacate.

Factual Background

The facts are fully set forth in our previous decision in this case. See Humphreys v. Drug Enforcement Administration, 96 F.3d 658, 659-60 (3d Cir.1996). To summarize, Humphreys was a Pittsburgh doctor specializing in internal medicine and gastroenterolo-gy. On April 12, 1995, a Deputy Assistant Administrator of the DEA issued to Hum-phreys an Order to Show Cause why the DEA should not revoke Humphreys’ certificate of registration under 21 U.S.C. § 824(a)(4) and deny any pending application under 21 U.S.C. § 823(f) as being inconsistent with the public interest. Specifically, the Order to Show Cause alleged that “from the early 1980s to mid-1993, [Humphreys] prescribed controlled substances to at least four individuals without a legitimate medical need and with knowledge that these individuals were not the ultimate recipients of the controlled substances.” [JA25] In short, in order to preserve the privacy of his patient of many years, former Pennsylvania Supreme Court Justice Rolf Larsen (“Larsen”), Humphreys prescribed various controlled substances, primarily anti-depressants, for Larsen in the name of certain of Larsen’s employees (secretaries and a law clerk).

After receiving the Order to Show Cause, Humphreys and his attorney each filed a response to the Order. Humphreys’ primary defense was that, by prescribing the medication in the names of Larsen’s close professional associates, he was merely attempting to protect Larsen’s privacy and doing so in a manner common and acceptable in standard medical practice for famous patients with mental conditions.

On January 23, 1996, the Deputy Administrator entered his Final Order. The Deputy Administrator acknowledged that he could revoke Humphreys’ registration only if continued registration would be inconsistent with the public interest pursuant to the five factors set forth in 21 U.S.C. § 823(f). The Deputy Administrator considered, discussed and relied upon each of the five factors except for factor three — Humphreys’ conviction record under Federal or State laws relating to controlled substances, which, because he had none, was not a relevant factor — and, based upon these factors, determined that the public interest would be best served by revoking Humphreys’ registration. The Deputy Administrator did not discuss, and apparently did not consider, Humphreys’ privacy defense.

Humphreys appealed and we vacated, in large part because the DEA utterly failed to consider Humphreys’ privacy defense. After our decision was filed, but before the mandate issued, Humphreys died. The DEA now requests that we vacate our previous decision, withdraw the opinion, and dismiss the appeal as moot.

Decision

I.

Generally, when a case becomes moot pending disposition of an appeal, the judgment below will be vacated and the case will be remanded with instructions to dismiss. See United States v. Munsingwear, 340 U.S. 36, 39-40, 71 S.Ct. 104, 106-07, 95 L.Ed. 36 (1950) (“The established practice of the Court in dealing with a civil case from a court in the federal system which has become moot while on its way here or pending our decision on the merits is to reverse or vacate the judgment below and remand with a direction to dismiss.”) (emphasis added) (dictum). The *114 purpose of such a practice is to prevent a party from being bound by a judgment the “review of which was prevented through happenstance.” Id. at 40, 71 S.Ct. at 107.

Munsingwear, however, is not universally applicable to all case's which seemingly become moot anytime during the appellate process. For example, previously issued decisions need not be vacated when a ease becomes moot due to settlement. U.S. Bancorp Mortgage Co. v. Bonner Mall Partnership, 513 U.S. 18, 115 S.Ct. 386, 130 L.Ed.2d 233 (1994). In U.S. Bancorp, after the Supreme Court had granted the petition for a writ of certiorari and received briefing, the parties entered into a consensual plan of reorganization which constituted a settlement of the case. 513 U.S. at —, 115 S.Ct. at 389. Bancorp requested that the Supreme Court vacate the decision of-the court of appeals; Bonner objected. Id. While recognizing that Munsingwear was applicable to situations in which a controversy presented for review had become moot due to circumstances unattributable to either party, the Supreme Court refused to extend Mun-singwear to a case which became moot due to settlement, stating that “[t]he principles that have always been implicit in our treatment of moot eases counsel against extending Munsingwear to settlement. From the beginning we have disposed of moot cases in the manner ‘most consonant to justice’ ... in view of the nature and character of the conditions which have caused the case to become moot.” Id. at —, 115 S.Ct. at 391. (citation omitted). Thus, Munsing-wear should not be applied blindly, but only after a consideration of the equities and the underlying reasons for mootness.

.The DEA has not cited any controlling precedent, either in the Third Circuit or the Supreme Court, that would require us to vacate our previously released decision and withdraw the opinion merely because Dr. Humphreys died before the Clerk’s Office issued the mandate; nor have we found any. Indeed, most analogous Supreme Court decisions suggest otherwise.

Free access — add to your briefcase to read the full text and ask questions with AI

Earl A. Humphreys, M.D. v. Drug Enforcement Administration, 105 F.3d 112, 1996 U.S. App. LEXIS 42576, 1996 WL 762112 (3d Cir. 1996).

105 F.3d 112 (Earl A. Humphreys, M.D. v. Drug Enforcement Administration) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Michael Romano v. Warden
Third Circuit, 2026
United States v. Jesus Perez Garcia
96 F.4th 1166 (Ninth Circuit, 2024)
Tanner Hirschfeld v. Bureau of Alcohol, Firearms, T
14 F.4th 322 (Fourth Circuit, 2021)
In Re: Da Graca v.
First Circuit, 2021
in Re: Bruce Bishop
Court of Appeals of Texas, 2020
Versata Software, Inc. v. Callidus Software, Inc.
780 F.3d 1134 (Federal Circuit, 2015)
Microsoft Corporation v. Itc
Federal Circuit, 2014
United States v. Payton
593 F.3d 881 (Ninth Circuit, 2010)
Arnott v. Internal Revenue Service (In Re Arnott)
395 B.R. 343 (W.D. Pennsylvania, 2008)
Barney O. Padgett v. James B. Peake
22 Vet. App. 159 (Veterans Claims, 2008)
Bastien v. Office of Senator Ben Nighthorse Campbell
409 F.3d 1234 (Tenth Circuit, 2005)
United States v. City of Detroit
401 F.3d 448 (Sixth Circuit, 2005)
United States v. The City Of Detroit
401 F.3d 448 (Sixth Circuit, 2005)
Donovan v. Punxsutawney Area School Board
336 F.3d 211 (Third Circuit, 2003)